| Code | CSB-MP007743HU-WD |
| Abbreviation | Recombinant Human EPO protein (Active) |
| MSDS | |
| Size | Inquiry |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
Erythropoietin drives red blood cell production through high-affinity engagement of the EPO receptor, and this recombinant form demonstrates potent bioactivity with an ED50 ≤0.01 ng/mL in TF-1 erythroleukemic cell proliferation assays, confirming receptor-binding competence at sub-picomolar concentrations. Expressed in mammalian cells to preserve the native N-glycosylation essential for in vivo stability and receptor activation, the protein spans residues 28–193, representing the full-length mature form that circulates physiologically. This low ED50 supports use in cell proliferation and survival assays, stem cell differentiation studies targeting erythroid lineages, and receptor-ligand binding experiments including ELISA and surface plasmon resonance. Purity exceeding 95% by SDS-PAGE and endotoxin levels ≤10 EU/mg align with standards expected in sensitive primary cell cultures and antibody characterization workflows.
There are currently no reviews for this product.